(Total Views: 681)
Posted On: 08/24/2020 6:43:03 PM
Post# of 153886
Re: CaptnAmerca #52003
And you can always do a thread. Even the bulletpoints are good. I'd maybe collapse it further:
Compared to standard of care (SOC), by day 3, leronlimab showed faster clinical improvement, which=less hospitalization, less cost to healthcare system, hospital and patients. SAE: SAFER than Placebo.
eIND from Montefiore showed
1. normalization of CD4/CD8 ratios
2. decrease of IL-6 and RANTES by day 3
3. decrease in viral loads by day 7 and *zero viral load* by day 14
In sum:
1. Save $$$
2. Safe drug to use
3. Get people out of the hospital quicker before they progress into S/C
Compared to standard of care (SOC), by day 3, leronlimab showed faster clinical improvement, which=less hospitalization, less cost to healthcare system, hospital and patients. SAE: SAFER than Placebo.
eIND from Montefiore showed
1. normalization of CD4/CD8 ratios
2. decrease of IL-6 and RANTES by day 3
3. decrease in viral loads by day 7 and *zero viral load* by day 14
In sum:
1. Save $$$
2. Safe drug to use
3. Get people out of the hospital quicker before they progress into S/C
(1)
(0)
